Flu Vaccine Clinical Trial For 65+
Actively Enrolling!
Flu Vaccine Study for Adults 65+
Believe it or not, flu viruses change every year.
That’s why the most effective way to help prevent flu
and its complications is by getting vaccinated every year!
This study is evaluating whether the investigational vaccine provides sufficient or better protection against seasonal flu compared to current vaccines, for participants who are 65 years of age and older. This investigational flu vaccine aims to enhance the immune system’s ability to recognize and fight off multiple flu virus strains. This may reduce the severity of illness and provide better protection.
About the GSK Flu Vaccine Study
The FLU SV mRNA-006 Vaccine study is testing a new investigational vaccine designed to protect against multiple influenza virus strains. This study will evaluate the clinical efficacy of the investigational vaccine in older adults 65 years of age.
You may be able to take part in the Flu Vaccine Study if you:
- Are aged 65 and older
- Are healthy with no major changes in your recent medical history
- Have not received vaccine against flu within the last 6 months
- Have not tested positive for the flu within the last 6 months
You may receive compensation up to $900 for inconvenience and travel.
If you are interested in participating, the study doctor and staff will review additional eligibility criteria with you and answer any questions you may have.
Call (561) 689-0606 or
Complete The Questionnaire Below To
To Submit Your Information For This Study
By participating in this clinical trial, you may reduce your risk of illness from the Flu while contributing to clinical research that could help protect millions of others around the world.
Call (561) 689-0606 or
Complete The Questionnaire Below To
To Submit Your Information For This Study
Diversity in Clinical Research Studies
People may experience the flu differently based on their race, ethnicity, gender, age, and background. Our GSK Flu Vaccine Study for 65+ is committed to including a diverse range of participants to ensure that people from various communities are represented, helping us understand how the investigational medication works across different groups. By prioritizing diversity, we can gain a more complete picture of its effectiveness, ultimately leading to better treatment options for everyone. Your unique experience matters in making a difference!
Why are clinical studies important?
Clinical trials are the best way to find out if new treatments or vaccines work and how safe they are. If clinical trials show that a new treatment works and is safe, then it can be approved to be used by the people who need it.
Not all clinical trials test a new treatment or vaccine. “Observational” studies collect information about people’s health during their normal care. This helps researchers learn more about specific health issues.
What is a clinical research study?
A clinical research study is a medical study that helps to answer important questions about an investigational medication or vaccine. such as:
- Is it effective?
- What amount. or dose. may work best?
- How safe is it?
- Are there side effects?
All medications and vaccines must be tested in clinical research studies before they can be approved for use. Without people taking part in these studies, we would have no new medications or vaccines
Clinical research studies should include groups of people who may be at higher risk based on their age, sex. and race/ethnicity.
An Institutional Review Board (IRB)/Ethics Committee (EC), which protects the rights, safety, and wellbeing of the participants has approved this study.
